Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Keywords

LungVirologyMedicineVirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusCoronavirus disease 2019 (COVID-19)Computational biologyBiologyInfectious disease (medical specialty)DiseasePathologyInternal medicine

MeSH Terms

AzetidinesBetacoronavirusCOVID-19Coronavirus InfectionsHumansPandemicsPneumoniaViralPurinesPyrazolesSARS-CoV-2SulfonamidesCOVID-19 Drug Treatment

Affiliated Institutions

Related Publications

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih‐Cheng Lai , Tzu-Ping Shih , Wen‐Chien Ko +2 more

2020 International Journal of Antimicrobia... 6277 citations

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou , Xing‐Lou Yang , Xian-Guang Wang +26 more

2020 Nature 22954 citations

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu , Hua Guo , Peng Zhou +1 more

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute re...

2020 Nature Reviews Microbiology 5269 citations

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann , Hannah Kleine‐Weber , Nadine Krüger +3 more

Abstract The emergence of a novel, highly pathogenic coronavirus, 2019-nCoV, in China, and its rapid national and international spread pose a global health emergency. Coronaviru...

2020 bioRxiv (Cold Spring Harbor Laboratory) 754 citations

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

Publication Info

Year: 2020
Type: letter
Volume: 395
Issue: 10223
Pages: e30-e31
Citations: 1452
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1452

OpenAlex

Influential

1155

CrossRef

Cite This

APA Style

                            
                                
                                    Peter J. Richardson, 
                                
                                    Ivan Griffin, 
                                
                                    Catherine Tucker
                                
                                et al.
                            
                            (2020). 
                            Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. 
                            The Lancet
                            , 395
                            (10223)
                            , e30-e31.
                            https://doi.org/10.1016/s0140-6736(20)30304-4
                        

Identifiers

DOI: 10.1016/s0140-6736(20)30304-4
PMID: 32032529
PMCID: PMC7137985

Data Quality

Data completeness: 72%